Aggressive versus moderate lipid-lowering therapy in postmenopausal women with hypercholesterolemia: Rationale and design of the Beyond Endorsed Lipid Lowering with EBT Scanning (BELLES) trial
- 1 May 2001
- journal article
- clinical trial
- Published by Elsevier in American Heart Journal
- Vol. 141 (5) , 722-726
- https://doi.org/10.1067/mhj.2001.114372
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Postmenopausal hormone use for cardioprotection: What we know and what we must learnCurrent Opinion in Cardiology, 1999
- Electron Beam Computed Tomographic Coronary Calcium Scanning: A Review and Guidelines for Use in Asymptomatic PersonsMayo Clinic Proceedings, 1999
- Effect of HMG-CoA Reductase Inhibitors on Coronary Artery Disease as Assessed by Electron-Beam Computed TomographyNew England Journal of Medicine, 1998
- Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol LevelsNew England Journal of Medicine, 1998
- The effect of hormone replacement therapy alone and in combination with simvastatin on plasma lipids of hypercholesterolemic postmenopausal women with coronary artery diseaseJournal of the American College of Cardiology, 1998
- Coronary artery disease: improved reproducibility of calcium scoring with an electron-beam CT volumetric method.Radiology, 1998
- Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal WomenJAMA, 1998
- The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol LevelsNew England Journal of Medicine, 1996
- Effects of estrogens on lipoprotein metabolism and cardiovascular disease in womenAtherosclerosis, 1994
- Metabolic risk factors for coronary heart disease in women: Perspective from the Framingham StudyAmerican Heart Journal, 1987